National MS Society: Positive Results Reported From a Phase 2 Trial of Stem Cell Therapy
December 24, 2020
December 24, 2020
NEW YORK, Dec. 24 (TNSRes) -- The National Multiple Sclerosis Society issued the following news:
A team from Israel's Hadassah University Hospital has published results from a phase 2 clinical trial of mesenchymal stem cell therapy in active, progressive MS. "Mesenchymal stem cells" are adult stem cells found in several places in the body, including the bone marrow, skin and fat tissue. Participants were 48 people with progressive MS with moderate to more severe disability . . .
A team from Israel's Hadassah University Hospital has published results from a phase 2 clinical trial of mesenchymal stem cell therapy in active, progressive MS. "Mesenchymal stem cells" are adult stem cells found in several places in the body, including the bone marrow, skin and fat tissue. Participants were 48 people with progressive MS with moderate to more severe disability . . .